Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BIOiSIMTM represents a groundbreaking 'virtual drug development engine' that significantly enhances the drug development sector by effectively identifying drug compounds that are most likely to provide meaningful therapeutic benefits for various diseases or conditions. We provide an array of translational solutions that are tailored to meet the specific needs of your pre-clinical and clinical initiatives. Central to our offerings is the highly validated BIOiSIMTM platform, which supports the development of small molecules, large molecules, and viruses. This innovative platform is underpinned by extensive data derived from thousands of compounds across seven different species, resulting in a level of robustness that is uncommon in the field. Emphasizing human health outcomes, the heart of the platform features a translatability engine that seamlessly converts insights gained from different species. Importantly, the BIOiSIMTM platform can be deployed prior to the initiation of preclinical animal trials, facilitating earlier insights and potentially reducing the costs associated with outsourced experimentation. By integrating these advanced capabilities, we aim to streamline the drug development process and accelerate the journey from discovery to market.
Description
DynaMedex merges the clinical acumen and meticulously curated disease information from DynaMed with the thorough overview of treatment options, expansive drug data, and AI-driven search functionalities of Micromedex. It equips users with evidence-based insights that facilitate superior clinical decision-making and enhance patient outcomes. Clinicians utilizing DynaMedex can effortlessly search, browse, and stay updated on the topics and specialties that are most relevant to their practice, receiving both quick responses and comprehensive insights into their drug inquiries. Delve into this innovative tool and discover how it fosters improved clinical decision-making. Users can swiftly obtain answers to their drug-related questions through intuitive and conversational search features. The "Ask Watson" assistant employs artificial intelligence to streamline access to drug information, eliminating the need for traditional keyword searches in favor of natural language queries, allowing users to communicate in their own words and receive the information they seek efficiently. This seamless integration of AI technology not only saves time but also empowers healthcare professionals to make informed decisions with greater ease.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
Free
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
VERISIMLife
Country
United States
Website
www.verisimlife.com/our-platform/
Vendor Details
Company Name
EBSCO
Country
United States
Website
www.ebsco.com/clinical-decisions/dynamed-solutions/dynamedex